ECCO 2019: Treatment of IBD with thiopurine and allopurinol vs thiopurine monotherapy

Sandra Bohn Thomsen | ECCO 2019 | Marts 8, 2019

Speaker: Sandra Bohn Thomsen

Thiopurine and allopurinol combination therapy is associated with clinical remission in patients with IBD, but its influence on adverse outcomes. In this study Sandra Bohn Thomsen et al. compared patients with IBD treated with thiopurine and allopurinol and patients with IBD treated with thiopurine monotherapy. Click and hear the result.